# Dexmedetomidine After Cesarean for the Treatment of Nausea and Shivering

> **NCT03370562** · NA · COMPLETED · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 100 (actual)

## Conditions studied

- Shivering
- Nausea and Vomiting, Postoperative

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03370562
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-18
- **Primary completion:** 2020-03-20
- **Final completion:** 2020-12-31
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2021-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03370562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03370562, "Dexmedetomidine After Cesarean for the Treatment of Nausea and Shivering". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03370562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*